High Growth Tech Stocks In The UK For May 2025

editorial-team@simplywallst.com (Simply Wall St)

Sun, May 11, 2025, 11:38 PM 4 min read

The United Kingdom's marketplace has precocious faced challenges, with the FTSE 100 scale experiencing a diminution owed to anemic commercialized information from China, highlighting concerns astir planetary economical betterment and its interaction connected UK companies tied to planetary markets. In this environment, identifying precocious maturation tech stocks requires focusing connected companies that show resilience and adaptability successful the look of fluctuating planetary conditions.

Click present to spot the afloat database of 38 stocks from our UK High Growth Tech and AI Stocks screener.

Let's reappraisal immoderate notable picks from our screened stocks.

Simply Wall St Growth Rating: ★★★★★☆

Overview: Redcentric plc is simply a UK-based institution that offers IT managed services to some nationalist and backstage sectors, with a marketplace capitalization of £201.47 million.

Operations: The institution generates gross chiefly from the proviso of managed services to customers, amounting to £167.94 million.

Redcentric, a UK-based IT managed work provider, has demonstrated robust fiscal wellness with an awesome 67.9% forecasted yearly net growth. Despite a challenging manufacture backdrop wherever the IT assemblage saw an mean diminution of 13.6% successful earnings, Redcentric has transitioned to profitability this year. The company's strategical absorption connected R&D is evident from its concern successful this area, which supports its innovative borderline successful a competitory market. With the caller assignment of Michelle Senecal De Fonseca arsenic CEO, who brings extended acquisition from Vodafone and Citrix Systems, Redcentric is poised to heighten its enactment successful unreality and hosting services portion maintaining a beardown dividend payout of 3.6 pence per stock for FY2025.

• Click to research a elaborate breakdown of our findings successful Redcentric's wellness report.

• Learn astir Redcentric's humanities performance.

Simply Wall St Growth Rating: ★★★★★☆

Overview: Oxford Biomedica plc is simply a declaration improvement and manufacturing enactment specializing successful delivering therapies globally, with a marketplace capitalization of £314.28 million.

Operations: Oxford Biomedica generates gross chiefly from manufacturing services (£68.35 million) and improvement activities (£47.27 million), with further income from licence fees and incentives (£7.33 million) and procurement and retention services (£5.85 million).